Centre Hospitalier Universitaire de Lille

Futó vizsgálatok

• Még nem toboroz

  Risk-reducing Strategies, Including Fimbriectomy, in Women With a Germline Mutation Predisposing to Ovarian or Pelvic Cancer

  NCT06726330· Centre Oscar Lambret· Forrás

• Még nem toboroz

  Evaluation of an Intensified Systematic Screening for Congenital Hypothyroidism in Premature Newborns

  NCT07425028· University Hospital, Lille· Forrás

• Még nem toboroz

  A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination with Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants with First-Line Metastatic Pancreatic Ductal Adenocarcinoma

  2025-522563-15-00· 2/3. fázis· AbbVie Deutschland GmbH & Co. KG· Forrás

• Még nem toboroz

  Safety and Efficacy of a STOPping Strategy Versus Classical Maintenance Dose of JAK Inhibitors in Deep Remission Patients With Ulcerative Colitis

  NCT07718529· 4. fázis· Assistance Publique Hopitaux De Marseille· Forrás

• Még nem toboroz

  Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic Leukemia With TP53 Alterations

  NCT07738887· 2. fázis· The Lymphoma Academic Research Organisation· Forrás

• Még nem toboroz

  Safety and Efficacy of VX-828/Deutivacaftor Combination Therapy With and Without Tezacaftor in Subjects With Cystic Fibrosis

  2025-523400-72-00· 2. fázis· Vertex Pharmaceuticals Inc.· Forrás

• Még nem toboroz

  A Multicenter Study of Belantamab Mafodotin and Mezigdomide in Patients With Relapsed Multiple Myeloma

  NCT07612787· 1/2. fázis· Centre Hospitalier Universitaire de Saint Etienne· Forrás

• Még nem toboroz

  FirST Lines of Biologics in pAtients With ulceRaTivE Colitis: a Randomised Controlled Trial

  NCT07576452· 4. fázis· University Hospital, Clermont-Ferrand· Forrás

• Még nem toboroz

  Evaluation of the Effect of Time of Administration on the Activity on First Line of Pembrolizumab in Association With Carboplatin-pemetrexed in Metastatic Non-squamous Lung Cancer. A Randomised Multicenter Phase III Trial

  NCT07915037· 3. fázis· Assistance Publique - Hôpitaux de Paris· Forrás

• Még nem toboroz

  A Phase 2 trial of AGMB-447 in participants with idiopathic pulmonary fibrosis

  2026-526404-71-00· 2. fázis· Agomab Spain S.L.U.· Forrás

• Toboroz

  Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease

  NCT07781657· 2. fázis· Hoffmann-La Roche· Forrás

• Még nem toboroz

  Efficacy of Upadacitinib Re-induction Therapy in Patients With Ulcerative Colitis Who Lost Response to 30 mg Maintenance Dose

  NCT07700446· 4. fázis· Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives· Forrás

• Még nem toboroz

  A study in young people and adults to learn about the medicine ritlecitinib for treatment of patchy hair loss, known by the medical term as moderate alopecia areata

  2026-526355-62-00· 3. fázis· Pfizer Inc.· Forrás

• Még nem toboroz

  A pivotal clinical study to investigate the safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis due to Metabolic dysfunction-associated steatohepatitis (MASH)

  2026-525755-82-00· 3. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Még nem toboroz

  A study to investigate safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis (stage F4 fibrosis) due to MASH (NEBULA-2)

  2026-525757-37-00· 3. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Még nem toboroz

  A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis

  NCT07873801· 3. fázis· Almirall, S.A.· Forrás

• Még nem toboroz

  Impact of a Diagnosis or Lack of a Diagnosis of Endometriosis Via a Saliva Test on Pain Catastrophizing, Quality of Life, Symptoms of Anxiety and Depression, and Treatment Adherence

  NCT07915765· University Hospital, Lille· Forrás

• Még nem toboroz

  Evaluation of iNstroke Aspiration Catheters for Thrombectomy: a Multi-center Prospective Study

  NCT07376447· iVascular S.L.U.· Forrás

• Még nem toboroz

  Therapeutic Implications of CMR Low Native T1 in Non-treated Non-hypertrophic Females With Fabry Disease (FD)

  NCT07872852· University Hospital, Bordeaux· Forrás

• Még nem toboroz

  Efficacy and Safety Evaluation of iNstroke 5F Aspiration Catheter for Thrombectomy

  NCT07571954· iVascular S.L.U.· Forrás

• Még nem toboroz

  A trial to learn how well AZD0120 works and about its safety in adults with transplant eligible newly diagnosed multiple myeloma.

  2026-525367-40-00· 3. fázis· AstraZeneca AB· Forrás

• Még nem toboroz

  A Multicenter, Phase 2/3, Dose Range Finding Study to Evaluate the Efficacy and Safety of Atumelnant in Adults with ACTH-Dependent Cushing’s Syndrome (ADCS) Including an Open-Label Extension for Long-Term Assessment. (EQUILIBRIUM-ADCS)

  2025-522648-42-01· 2/3. fázis· Crinetics Pharmaceuticals Inc.· Forrás

• Még nem toboroz

  Bioavailability and Bioequivalence Study of Ziftomenib in Participants With Relapsed/Refractory AML or MDS

  NCT07929740· 1. fázis· Kura Oncology, Inc.· Forrás

• Még nem toboroz

  A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity

  NCT07861100· 3. fázis· Novo Nordisk A/S· Forrás

• Még nem toboroz

  Comparative Study of Two Vaccination Schedules for the Subunit Herpes Zoster Vaccine in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease Patients Treated With Anti-CD20 Therapy: an Open-label Randomised Controlled Trial

  NCT07818356· 4. fázis· University Hospital, Toulouse· Forrás

• Toboroz

  A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A

  NCT07830732· 3. fázis· Novo Nordisk A/S· Forrás

• Még nem toboroz

  Impact of Fluorescence-Guided Resection and Chemoradiotherapy on the Systemic Immune Response in Glioblastoma: A Kinetic Analysis of Immune Biomarkers.

  NCT07568782· University Hospital, Lille· Forrás

• Még nem toboroz

  Evaluation of the Efficacy and Safety of Bimekizumab (BZK) or Adalimumab (ADA) in the Treatment of Anterior Chest Wall Pain Associated With Active Axial Spondyloarthritis Refractory to NSAIDs With Hypothesis of Superiority of Bimekizumab

  NCT07836283· 3. fázis· University Hospital, Rouen· Forrás

• Toboroz

  A Phase IIa Trial Evaluating the Efficacy of anti-CD19 Chimeric Antigen Receptor Engineered T-Cells in Patients With Systemic Sclerosis (SSc) Resistant to Immunosuppressive Drugs. SCLEROCAR

  2024-519511-33-00· 2. fázis· Centre Hospitalier Universitaire De Montpellier· Forrás

• Toboroz

  Phase 3 Study of Investigator Choice of Chemotherapy with or without Zoldonrasib as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma

  2025-524928-21-00· 3. fázis· Revolution Medicines Inc.· Forrás

• Toboroz

  Switch to Ofatumumab and Level of Immunoglobulins

  NCT07625800· University Hospital, Lille· Forrás

• Még nem toboroz

  A clinical trial to learn more about the effects of DJI136 in people with extensive-stage small cell lung cancer

  2025-523276-23-00· 1/2. fázis· Novartis Pharma AG· Forrás

• Toboroz

  Study of 18FET PET in functional pituitary adenomas with indeterminate MRI findings

  2025-523829-17-00· 2. fázis· Centre Hospitalier Universitaire De Lille· Forrás

• Még nem toboroz

  Perioperative Yoga Therapy and Endometriosis Surgery

  NCT07765680· University Hospital, Lille· Forrás

• Még nem toboroz

  Evaluation of the Axomove Therapy Medical Device to Facilitate Adapted Physical Activity for Patients With Obesity

  NCT07903025· Axomove· Forrás

• Még nem toboroz

  Tenecteplase for the treatment of acute stroke in the late time window before inter-hospital transfer for thrombectomy: a randomized controlled trial

  2026-525280-40-00· 3. fázis· Fondation A De Rothschild· Forrás

• Még nem toboroz

  Evaluate the superiority of Treatment with RAvulizumab vs plasma exchange during the first episode or a relapse In acute neuromyelitis optica (NMO) patients: a national, multicentric, randomised trial

  2026-526632-39-00· 3. fázis· Les Hopitaux Universitaires De Strasbourg· Forrás

• Toboroz

  ODSSEY-SCD_Identification Of Markers to preDict the rISk of Sudden Cardiac Death in Moderated LVEF in ischEmic cardiomyopathY

  NCT07545512· University Hospital, Clermont-Ferrand· Forrás

• Toboroz

  A Phase 3 Study Comparing Ramantamig plus Daratumumab Versus DVRd or DRd in Participants With NDMM for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy

  2026-526654-14-01· 3. fázis· Janssen Cilag International· Forrás

• Toboroz

  A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

  NCT07465289· 3. fázis· UCB Biopharma SRL· Forrás

• Még nem toboroz

  Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease

  NCT07420439· 2. fázis· Intergroupe Francophone de Cancerologie Thoracique· Forrás

• Toboroz

  A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

  NCT07623161· 3. fázis· Takeda· Forrás

• Toboroz

  A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)

  2025-525009-18-00· 3. fázis· Incyte Corp.· Forrás

• Toboroz

  A trial to learn how well AZD0120 works and how safe it is in people with relapsed or refractory multiple myeloma.

  2025-523285-25-00· 3. fázis· AstraZeneca AB· Forrás

• Toboroz

  A Phase IIb Study to Evaluate AZD8965 in Participants with Idiopathic Pulmonary Fibrosis (IPF)

  2025-525016-41-00· 2. fázis· AstraZeneca AB· Forrás

• Még nem toboroz

  Obinutuzumab for Systemic Lupus Erythematosus Pure Membranous Nephropathy: a Phase II Trial

  NCT07721363· 2. fázis· Assistance Publique - Hôpitaux de Paris· Forrás

• Még nem toboroz

  Prospective evaluation of response to treatment by analysis of measurable residual disease in younger adult patients (18-60 years) with acute myeloid leukemia (AML). The Backbone InterGroup (BIG)-2 umbrella trial from the Acute Leukemia French Intergroup (ALFA, FILO) - BIG2

  2026-525759-96-00· 4. fázis· Centre Hospitalier Universitaire De Toulouse· Forrás

• Még nem toboroz

  Short- and Mid-term Therapeutic, Prognostic, and Societal Impact of Implementing Intraoperative Assessment of Pulmonary Resection Quality for Lung Cancer

  NCT07828938· Fondation Hôpital Saint-Joseph· Forrás

• Még nem toboroz

  Evaluation of the Efficacy of Ischemic Preconditioning to Protect Against Acute Kidney Injury After Open Surgery for Juxtarenal Abdominal Aortic Aneurysm

  NCT07441564· University Hospital, Rouen· Forrás

• Még nem toboroz

  CUSHMAH - Benefit of steroidogenesis inhibitors in Mild Cushing syndrome (Mild Autonomous Cortisol Secretion): a randomized trial in patients with Primary Bilateral Macronodular Adrenocortical Hyperplasia

  2023-507010-27-00· 3. fázis· Assistance Publique Hopitaux De Paris· Forrás

Showing 50 of 635.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák33 toboroz
• Gyermekkori daganatok24 toboroz
• Mielóma multiplex22 toboroz
• Crohn-betegség17 toboroz
• Akut mieloid leukémia (AML)16 toboroz
• Vastagbélrák16 toboroz
• Gyomor- és nyelőcsőrák15 toboroz
• Hasnyálmirigyrák15 toboroz
• Stroke (szélütés)14 toboroz
• Sclerosis multiplex (SM)12 toboroz
• Akut limfoid leukémia (ALL)11 toboroz
• Colitis ulcerosa9 toboroz
• Epilepszia9 toboroz
• Magas vérnyomás9 toboroz
• Máj- és epeúti rák9 toboroz
• Melanóma9 toboroz
• Koszorúér-betegség8 toboroz
• Szisztémás szklerózis (szkleroderma)8 toboroz
• Hemofília7 toboroz
• Mielodiszplasztikus szindróma (MDS)7 toboroz
• Myasthenia gravis7 toboroz
• Parkinson-kór7 toboroz
• Zsírmáj (MASLD/MASH)7 toboroz
• Follikuláris limfóma6 toboroz
• Krónikus mieloid leukémia (CML)6 toboroz
• Petefészekrák6 toboroz
• Szívelégtelenség6 toboroz
• Alzheimer-kór5 toboroz
• Idiopátiás tüdőfibrózis5 toboroz
• Krónikus limfoid leukémia (CLL)5 toboroz
• Neuroendokrin daganatok5 toboroz
• Prosztatarák5 toboroz
• 1-es típusú cukorbetegség4 toboroz
• Aortic aneurysm4 toboroz
• Aortic stenosis4 toboroz
• Cushing's syndrome4 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)4 toboroz
• Duchenne-izomdisztrófia4 toboroz
• Hólyagrák4 toboroz
• Krónikus obstruktív tüdőbetegség (COPD)4 toboroz
• Lupus (SLE)4 toboroz
• Mieloproliferatív neopláziák4 toboroz
• Amiotrófiás laterálszklerózis (ALS)3 toboroz
• ANCA-asszociált vasculitis3 toboroz
• Asztma3 toboroz
• Atópiás dermatitisz (ekcéma)3 toboroz
• Dermatomyositis and polymyositis (myositis)3 toboroz
• Dilated cardiomyopathy3 toboroz
• Elhízás3 toboroz
• Fej-nyaki daganatok3 toboroz
• Glioblasztóma3 toboroz
• Hodgkin-limfóma3 toboroz
• Köpenysejtes limfóma3 toboroz
• Mezotelióma3 toboroz
• Neuromyelitis optica (NMOSD)3 toboroz
• Pajzsmirigyrák3 toboroz
• Pitvarfibrilláció3 toboroz
• Sarlósejtes vérszegénység3 toboroz
• Vesedaganat3 toboroz
• 2-es típusú cukorbetegség2 toboroz
• Aplastic anaemia2 toboroz
• Arthritis psoriatica2 toboroz
• Barrett's oesophagus2 toboroz
• Cisztás fibrózis2 toboroz
• Congenital heart disease2 toboroz
• Cytomegalovirus infection2 toboroz
• Depresszió2 toboroz
• Endometriózis2 toboroz
• Hidradenitis suppurativa2 toboroz
• Krónikus gyulladásos demielinizációs polineuropátia (CIDP)2 toboroz
• Lewy-testes demencia2 toboroz
• Liver cirrhosis2 toboroz
• Osteoarthritis2 toboroz
• Pikkelysömör2 toboroz
• Primer biliáris cholangitis (PBC)2 toboroz
• Rheumatoid arthritis2 toboroz
• Sarcoidosis2 toboroz
• Skizofrénia2 toboroz
• Alopecia areata1 toboroz
• Amiloidózis1 toboroz
• Bronchiectasis1 toboroz
• Csontritkulás1 toboroz
• Fabry-betegség1 toboroz
• Familiáris hiperkoleszterinémia1 toboroz
• Hepatitis B (krónikus)1 toboroz
• Hepatitis C1 toboroz
• Hipertrófiás kardiomiopátia1 toboroz
• Huntington-kór1 toboroz
• Hypothyroidism1 toboroz
• IgA-nefropátia1 toboroz
• Insomnia1 toboroz
• Irritable bowel syndrome1 toboroz
• Krónikus vesebetegség1 toboroz
• Méhnyakrák1 toboroz
• Méhtestrák1 toboroz
• Myocarditis1 toboroz
• Neuroblasztóma1 toboroz
• Obstructive sleep apnoea1 toboroz
• Policisztás vesebetegség1 toboroz
• Pulmonális artériás hipertónia1 toboroz
• Sjögren-szindróma1 toboroz
• Spinális izomatrófia (SMA)1 toboroz
• Spondylitis ankylopoetica (Bechterew-kór)1 toboroz
• Szarkóma1 toboroz

Lezárt vizsgálatok

• Visszavonták

  Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab

  NCT07039422· 2. fázis· Novartis Pharmaceuticals· Forrás

• Lezárult

  Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults with Advanced Colorectal Cancer.

  2025-523984-39-00· 2. fázis· Gilead Sciences Inc.· Forrás

• Lezárult

  A clinical trial to learn about the effects of VHB937 in people with Alzheimer's disease

  2024-516966-12-00· 2. fázis· Novartis Pharma AG· Forrás

• Lezárult

  Study of the Effectiveness and Safety of Acasunlimab Alone or With Pembrolizumab in treating Advanced Melanoma of the Skin That Has Returned After or did not respond to Cancer Immunotherapy (ABBIL1TY MELANOMA-07)

  NCT06984328· 2. fázis· Genmab A/S· Forrás

• Fut, nem toboroz

  A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma

  NCT07288203· 2. fázis· Iovance Biotherapeutics, Inc.· Forrás

• Lezárult

  GSK4527226 Open-label Extension Study in Patients with Early Alzheimer's Disease.

  2025-521107-42-00· 2. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Lezárult

  Evaluation of long-term safety in parkinsonian patients with intracerebroventricular administration of A-dopamine (anaerobic dopamine) - (DIVE-Follow up)

  2025-522261-30-00· 1/2. fázis· Centre Hospitalier Universitaire De Lille· Forrás

• Még nem toboroz

  Evaluation of Efficacy and Safety De-escalation Versus Standard Adjuvant Chemotherapy in Patients With Low Risk Localized Gastroesophageal Adenocarcinoma

  NCT06933966· 2. fázis· Centre Leon Berard· Forrás

• Lezárult

  A multicentre, randomised, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of BP1.4979 in adult patients with essential tremor

  2024-517987-46-00· 2. fázis· Bioprojet Pharma· Forrás

• Lezárult

  C4971006: A Study to Learn About the Effects of 2 Study Medicines (Maplirpacept [PF-07901801] and Glofitamab) When Given Together in People With Relapsed or Refractory Diffuse Large B Cell Lymphoma

  NCT05896163· 1/2. fázis· Pfizer Inc.· Forrás

• Lezárult

  A Phase 3, Open-Label, Long-Term Safety Extension Study Evaluating the Safety and Tolerability of the Fixed-Dose Combination of Obeticholic Acid and Bezafibrate in Subjects with Primary Biliary Cholangitis

  2023-507771-22-01· 3. fázis· Intercept Pharmaceuticals Inc.· Forrás

• Lezárult

  Characterization of Immune Response in Participants from a Posdinemab Study

  2024-514634-20-00· 1. fázis· Janssen Cilag International· Forrás

• Fut, nem toboroz

  A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)

  NCT06593522· 2. fázis· Amgen· Forrás

• Lezárult

  A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

  NCT06637423· 1/2. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  IFM 2020-01 (Isamyp) Efficacity assessment of isatuximab plus pomalidomide and dexamethasone in patients with AL amyloidosis who didn't reach at least a very good partial response with their previous treatment

  NCT05066607· 2. fázis· Intergroupe Francophone Du Myelome· Forrás

• Lezárult

  Efficacy, Safety and Tolerability of BHV-7000 in Subjects with Idiopathic Generalized Epilepsy with Generalized Tonic-clonic Seizures – SHINE

  NCT06425159· 2/3. fázis· Biohaven Therapeutics Ltd.· Forrás

• Lezárult

  A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of Abiprubart in Participants with Sjögren’s Disease

  2024-512986-15-00· 2. fázis· Kiniksa Pharmaceuticals GmbH· Forrás

• Lezárult

  ALS Phase II Study of NX210c

  NCT06365216· 2. fázis· Axoltis Pharma· Forrás

• Toboroz

  Efficacy and safety study of frexalimab (SAR441344) in adults with relapsing forms of multiple sclerosis

  2023-504358-36-00· 3. fázis· Sanofi-Aventis Recherche & Developpement· Forrás

• Fut, nem toboroz

  To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications

  NCT06553027· 3. fázis· Cerevance· Forrás

• Lezárult

  A study to test whether BI 1839100 improves cough in people with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis

  2023-510249-79-00· 2. fázis· Boehringer Ingelheim International GmbH· Forrás

• Fut, nem toboroz

  Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome

  NCT06315751· 2. fázis· Noema Pharma AG· Forrás

• Lezárult

  A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

  NCT06335303· 2. fázis· Boehringer Ingelheim· Forrás

• Fut, nem toboroz

  A Phase 1b Trial to Evaluate Safety of MB097 in Combination With Pembrolizumab in Melanoma Patients

  NCT06540391· 1. fázis· Microbiotica Ltd· Forrás

• Lezárult

  Molecular Analysis of Thrombocytopenia and Cancer (MATAC): Investigating Antigenic Mimicry Between Platelets and Tumor Cells in Patients With Immune Thrombocytopenia (ITP) Associated With Cancer

  NCT06444477· University Hospital, Bordeaux· Forrás

• Lezárult

  Reperfusion with P2Y12 inhibitors in addition to mechanical thrombectomy for perfusion imaging selected acute stroke patients : a multicentric randomized controlled trial

  NCT04667078· 4. fázis· Fondation A De Rothschild· Forrás

• Fut, nem toboroz

  NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.

  NCT06379217· 1. fázis· Novartis Pharmaceuticals· Forrás

• Lezárult

  A randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of PLN-74809 (bexotegrast) for the treatment of idiopathic pulmonary fibrosis (BEACON-IPF)

  2023-506185-31-00· 2/3. fázis· Pliant Therapeutics Inc.· Forrás

• Fut, nem toboroz

  Lenvatinib Treatment in Waiting List of Liver Transplantation After TACE Failure in Patients With Hepatocellular Carcinoma

  NCT05901194· 1/2. fázis· Assistance Publique - Hôpitaux de Paris· Forrás

• Lezárult

  A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid.

  NCT06383403· 3. fázis· Ipsen· Forrás

• Leállították

  To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate

  NCT06488911· 3. fázis· Intercept Pharmaceuticals· Forrás

• Lezárult

  Open-label Extension of Vericiguat in Pediatric Participants with Heart Failure due to Left Ventricular Systolic Dysfunction

  2023-506210-40-00· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Performance and Hearing-related Outcomes in Adults Implanted With the CI622D Dexamethasone-eluting Cochlear Implant Compared to Those Implanted With a Standard Cochlear Implant (CI622)

  NCT06424262· Cochlear· Forrás

• Lezárult

  Inflammatory Response in Children Suffering From Tethered Cord

  NCT07611058· University Hospital, Lille· Forrás

• Lezárult

  A Phase 1/2, Open-Label, Multicenter Trial Investigating the Safety, Tolerability, and Preliminary Antineoplastic Activity of IPH6501 in Patients with Relapsed and/or Refractory CD20-expressing Non-Hodgkin Lymphoma

  NCT06088654· 1/2. fázis· Innate Pharma· Forrás

• Lezárult

  EFFICACY AND SAFETY OF GSK4527226 [AL101] IN PATIENTS WITH EARLY ALZHEIMER’S DISEASE

  NCT06079190· 2. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Lezárult

  Glenzocimab in Anterior stroke with Large Ischemic Core eligible for Endovascular therapy

  2023-509615-92-00· 2. fázis· Hopital Fondation Adolphe De Rothschild· Forrás

• Fut, nem toboroz

  A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)

  NCT06346067· 3. fázis· Erasca, Inc.· Forrás

• Lezárult

  A 52-week Clinical Trial to Study the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)

  NCT05813288· 3. fázis· Areteia Therapeutics Inc.· Forrás

• Lezárult

  A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments

  NCT06323928· 2. fázis· H. Lundbeck A/S· Forrás

• Toboroz

  A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

  NCT05509777· 3. fázis· Eli Lilly and Company· Forrás

• Lezárult

  A clinical study of MK-6194 for the treatment of Systemic Lupus Erythematosus (SLE) (MK-6194-006)

  2023-505520-61-00· 2/3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  A Phase 3 Study to Evaluate the Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants with Relapsed or Refractory Multiple Myeloma (RRMM)

  2023-509472-42-00· 3. fázis· Celgene International II S.a.r.l.· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor

  NCT06241118· 3. fázis· Sanofi· Forrás

• Visszavonták

  Home Monitoring of Adult Patients With SMA: a Pilot Multicenter Validation Study

  NCT05839145· Institut de Myologie, France· Forrás

• Lezárult

  A 96-Week, Prospective, Multicenter, Randomised, Double-Blind, Placebo-Controlled, Phase 3 Study to Compare Efficacy and Safety of Masitinib Dose Titration to 4.5 mg/kg/day versus Placebo in the Treatment of Patients with Primary Progressive or Secondary Progressive Multiple Sclerosis Without Relapse

  2024-516672-16-00· 3. fázis· Ab Science· Forrás

• Lezárult

  A trial to find out if vidutolimod together with cemiplimab is safe and if it works in adult participants with advanced cancer or metastatic cancer

  NCT04916002· 2. fázis· Regeneron Pharmaceuticals Inc.· Forrás

• Fut, nem toboroz

  A Study to Evaluate ABP 206 Compared with OPDIVO® (Nivolumab) in Subjects with Unresectable or Metastatic Melanoma

  2023-503288-40-00· 3. fázis· Amgen Inc.· Forrás

• Leállították

  Safety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AML

  NCT06268574· 2. fázis· Ryvu Therapeutics SA· Forrás

• Lezárult

  A Multicenter, Open-Label Clinical Trial of RVU120 in Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia with or without NPM1 Mutation (RIVER-52)

  2023-505910-10-00· 2. fázis· Ryvu Therapeutics S.A.· Forrás

Showing 50 of 238.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Mielóma multiplex51 munka · 61 vizsgálat
• Sclerosis multiplex (SM)43 munka · 28 vizsgálat
• Szisztémás szklerózis (szkleroderma)31 munka · 15 vizsgálat
• Hólyagrák28 munka · 10 vizsgálat
• Akut mieloid leukémia (AML)28 munka · 33 vizsgálat
• Crohn-betegség27 munka · 28 vizsgálat
• Pulmonális artériás hipertónia18 munka · 8 vizsgálat
• Hodgkin-limfóma16 munka · 19 vizsgálat
• Frontotemporális demencia16 munka · 1 vizsgálat
• Follikuláris limfóma15 munka · 19 vizsgálat
• Cisztás fibrózis14 munka · 5 vizsgálat
• Hemofília11 munka · 16 vizsgálat
• Cytomegalovirus infection10 munka · 2 vizsgálat
• Mezotelióma9 munka · 10 vizsgálat
• Mielodiszplasztikus szindróma (MDS)8 munka · 17 vizsgálat
• Köpenysejtes limfóma7 munka · 10 vizsgálat
• Immune thrombocytopenia (ITP)6 munka · 5 vizsgálat
• ANCA-asszociált vasculitis5 munka · 5 vizsgálat
• Neuromyelitis optica (NMOSD)5 munka · 4 vizsgálat
• Dermatomyositis and polymyositis (myositis)5 munka · 6 vizsgálat
• Retinitis pigmentosa4 munka · 0 vizsgálat
• Aplastic anaemia3 munka · 2 vizsgálat